Use: Labeled indications
- Uses Temporarily relieves burning and irritation due to dryness of the eye. discomfort due to minor irritations of the eye or to exposure to wind or sun.
Full indications and usage US FDA label
Uses Temporarily relieves burning and irritation due to dryness of the eye. discomfort due to minor irritations of the eye or to exposure to wind or sun.
Dosing: Adult
Dosage and administration (US label) US FDA label
Directions instill 1 or 2 drops in the affected eye(s) as needed
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Ophthalmic solution: 3 mg/mL, 5 mg/mL, 7 mg/mL
- Sterile ophthalmic solution: 3 mg/mL
- Ophthalmic drops solution: 30 mg/10 mL
- Sterile ophthalmic drops: 3 mg/mL
Registered products in the Philippines
25 products registered with the Food and Drug Administration (FDA) Philippines list Hypromellose as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Hydroxypropyl Methylcellulose (1 product) · Hydroxypropylmethylcellulose (1 product) · Hypromellos (1 product). Products registered under these spellings are included in the table and marked.
All registered products25
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AcceprosHypromellose | 3 mg/mL (0.3% w/v) Ophthalmic SolutionWhite HDPE Bottle x 10 mL (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-17092 | Sep 30, 2030 | |
ArtiblemoseHypromellose | 3 mg/mL (0.3% w/v) Ophthalmic SolutionGreen LDPE Bottle with Nozzle and Cap x 5 mL and 10 mL (Box of 1's) | OTC | Makcur Laboratories LimitedIndia | Afree Pharmaceutical Distribution CorpImporter: Afree Pharmaceutical Distribution Corp. | DRP-14589 | Oct 19, 2028 | |
AurosolHypromellose | 7 mg/mL (0.7% w/v) Ophthalmic SolutionLDPE Bottle x 10 mL (Box of 1's) | Rx | AurolabIndia | Brady Pharma Inc. | DRP-5157 | Mar 6, 2028 | |
3 mg/mL (0.3%) Sterile Ophthalmic Solution (Drops)LDPE White Bottle with HDPE White Cap x 10 mL (Box of 1’s) | Rx | Laboratorios Ashford Lda.China | Marrion Pharma Inc. | DRP-6034 | Feb 9, 2037 | ||
Equisine MoistHypromellose | 30mg/10mL (0.3% w/v) Ophthalmic Drops SolutionLDPE Plastic Bottle x 10mL with HDPE Cap Box of 1's | Rx | Duopharma (M) Sdn. Bhd.Malaysia | DB (Philippines), Inc. | DR-XY41287 | Oct 3, 2027 | |
3 mg/mL (0.3% w/v) Sterile Ophthalmic DropsLDPE Bottle with LDPE plug and HDPE cap x 10 mL (Box of 1's) | OTC | Duopharma (M) Sdn. Bhd.Malaysia | TGP The Generics PharmacyImporter: DB (Philippines), Inc.Trader: CCM Marketing Sdn Bhd | DR-XY37600 | Mar 15, 2027 | ||
Eye Mo Moisturizing FormulaHypromellose | 3 mg/mL Ophthalmic SolutionOpaque HDPE plastic bottle with pilfer-proof cap x 7.5 mL (Box of 1's) | OTC | PT. Pharma Health CareIndonesia | Importer: Integrated Market Services (Philippines) Inc. | DR-XY35419 | May 14, 2027 | |
Eye-KhrizHypromellose | 3mg/mL (0.3% w/v) Ophthalmic SolutionPP Sterile Bottle x 10 mL (Box of 1's) | OTC | Merit Organics Ltd. | Khriz Pharma Trading Inc. | DR-XY49774 | Jul 28, 2031 | |
5 mg/mL Ophthalmic SolutionWhite HDPE Plastic Bottle x 10 mL with Transparent Nozzle and PVC Cap (Box of 1's) | Rx | Remington Pharmaceutical Industries (Pvt.) Ltd.Pakistan | Ophthamed Pharma Corp. | DRP-12259 | May 9, 2029 | ||
Hyper-MoistHypromellose | 3mg/mL (0.3% w/v) Ophthalmic SolutionLDPE vial x 10 mL with spike cap (Box of 1's) | Rx | Axa Parenterals LimitedIndia | Brady Pharma Inc. | DRP-14018 | Jun 6, 2028 | |
HyproCareHypromellose | 3 mg / mL (0.3% w/v) Ophthalmic SolutionLDPE Plastic Bottle x 10 mL (Box of 1's) | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Sensorycare Pharma Co.Trader: Medilife Pharma, Inc | DRP-498-06 | Mar 8, 2030 | |
HypromaxHypromellose | 3 mg/mL (0.3%) Sterile Ophthalmic SolutionWhite Colored HDPE Dropper Bottle x 10 mL (Box of 1's) | OTC | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Vendiz Pharmaceuticals Inc. | DRP-2236 | Mar 4, 2029 | |
HyproSaveHypromellose | 3 mg/mL (0.3% w/v) Ophthalmic SolutionWhite HDPE Bottle x 10 mL (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Savelink Pharma And Trading Co.Importer: Accesspoint International Trading Inc. | DRP-17092-02 | Sep 30, 2030 | |
HyprosolHypromellose | 3 mg/mL Ophthalmic SolutionWhite LDPE Dropper Bottle with HDPE Tamper Evident Screw cap and white LDPE Dropper x 10 mL (Box of 1's) | Rx | BEXIMCO PHARMACEUTICALS LTD.Bangladesh | AGLOBAL CARE, INC. | DRP-11532 | Feb 9, 2028 | |
IkshartiHypromellose | 3 mg/mL (0.3% w/v) Ophthalmic SolutionGreen LDPE Bottle with nozzle and Cap x 5mL and 10mL (Box of 1) | OTC | Makcur Laboratories LimitedIndia | Bliss Pharma Distribution and Consultancy Corp.Importer: Afree Pharmaceutical Distribution Corp. | DRP-14589-01 | Oct 19, 2028 | |
ILUBEHypromellose | 3 mg/mL (0.3 % w/v) Ophthalmic SolutionLDPE Plastic Bottle x 10 mL Box of 1's | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Medilife Pharma, Inc. | DRP-498 | Mar 8, 2030 | |
MellotearsHypromellose | 3 mg/mL (0.3% w/v) Ophthalmic SolutionOpaque Bottle with Nozzle and Cap x 5mL (Box of l's) | OTC | Indiana OphthalmicsIndia | Aglobal Care, Inc. | DRP-11825 | May 5, 2027 | |
MistyHypromellose | 3 mg/mL Ophthalmic SolutionLDPE Bottle x 10 mL (Box of 1's) | Rx | Millimed BFS Co., Ltd.Thailand | Atlantic Pharmaceuticals Inc. | DR-XY47973 | Apr 28, 2027 | |
MoisolHypromellose | 7 mg/mL (0.7% w/v) Ophthalmic Solution (Eye Drops)Low Density Polyethylene (LDPE) Plastic Bottle x 5 mL with High Impact Polystyrene (HIPS) Spike Cap (Box of 1's) | Rx | FDC LimitedIndia | Penta Labs Australia (Philippines) | DRP-6186 | Jun 16, 2030 | |
NoneHypromellose | 3 mg/ mL (0.3% w/v) Ophthalmic SolutionLDPE Plastic Bottle x 10 mL (Box of 1's) | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Celsus Pharmaceuticals Phils., Inc.Trader: Medilife Pharma, Inc. | DRP-498-05 | Mar 8, 2030 | |
NoneHypromellose | 3 mg/mL (0.3% w/v) Ophthalmic SolutionWhite HDPE Bottle x 10 mL (Box of 1's) | OTC | Opal Laboratories (Pvt.) LimitedPakistan | Reta DrugImporter: Accesspoint International Trading Inc. | DRP-17092-01 | Sep 30, 2030 | |
NoneHypromellose | 3 mg/mL (0.3%) Ophthalmic Solution (Drops)Plastic Bottle X 10 mL (Box of 1's) | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Importer: Sensomed Phils., Inc. | DR-XY33428 | Jun 6, 2027 | |
SaphmelloseHypromellose | 3 mg/mL (0.3% w/v) Ophthalmic SolutionWhite HDPE Dropper Bottle with Close Nozzle and Pilferproof Ring Cap x 5 mL, 7.5 mL and 10 mL (Box of 1's) | OTC | Anhil Parenterals Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-11269 | Mar 8, 2027 | |
TirvedaHypromellose | 3 mg/mL (0.3 % w/v) Ophthalmic SolutionGreen LDPE Bottle with Nozzle and Cap x 5 mL and 10 mL (Box of 1's) | OTC | Makcur Laboratories LimitedIndia | Triple Tact Import & Export Corp.Importer: Afree Pharmaceutical Distribution Corp. | DRP-14589-02 | Oct 19, 2028 | |
VistatearsHypromellose | 5 mg/mL Ophthalmic Solution (Drops)10 mL HDPE pilfer-guard eyedropper plastic container in a box | Rx | EL Laboratories, Inc.Philippines | Trader: Vista Pharma, Inc. | DR-XY31929 | Apr 16, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings For external use only. Do not use if solution changes color or becomes cloudy. When using this product do not touch tip of container to any surface to avoid contamination. replace cap after using. Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye. condition worsens or persists for more than 72 hours. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Hypromellose Eye Drops Solution 5 mg/mL, 10 mL Bottle | ₱179.00–₱250.00Reference ₱179.00 | per bottle | DPRI procurement range |
Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Hypromellose |
| PNF listing | Eye Drops Solution: 5 mg/mL and 10 mg/mL, 10 mL and 15 mL bottle |
| PNF listing | Ophthalmic Solution: 0.3%, 10 mL bottle |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Splash Tears · LABORATORIOS SOPHIA, S.A. DE C.V. [US FDA-approved label, version 10, May 8, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a58a8478-9cc5-aa39-e053-2995a90a347d
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .